342 related articles for article (PubMed ID: 33090732)
1. High levels of modified ceramides are a defining feature of murine and human cancer cachexia.
Morigny P; Zuber J; Haid M; Kaltenecker D; Riols F; Lima JDC; Simoes E; Otoch JP; Schmidt SF; Herzig S; Adamski J; Seelaender M; Berriel Diaz M; Rohm M
J Cachexia Sarcopenia Muscle; 2020 Dec; 11(6):1459-1475. PubMed ID: 33090732
[TBL] [Abstract][Full Text] [Related]
2. Association of circulating PLA2G7 levels with cancer cachexia and assessment of darapladib as a therapy.
Morigny P; Kaltenecker D; Zuber J; Machado J; Mehr L; Tsokanos FF; Kuzi H; Hermann CD; Voelkl M; Monogarov G; Springfeld C; Laurent V; Engelmann B; Friess H; Zörnig I; Krüger A; Krijgsveld J; Prokopchuk O; Fisker Schmidt S; Rohm M; Herzig S; Berriel Diaz M
J Cachexia Sarcopenia Muscle; 2021 Oct; 12(5):1333-1351. PubMed ID: 34427055
[TBL] [Abstract][Full Text] [Related]
3. Specific miRNAs are associated with human cancer cachexia in an organ-specific manner.
Krauss T; Heisz S; Honecker J; Prokopchuk O; Martignoni M; Janssen KP; Claussnitzer M; Hauner H; Seeliger C
J Cachexia Sarcopenia Muscle; 2023 Jun; 14(3):1381-1394. PubMed ID: 37021483
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial degeneration precedes the development of muscle atrophy in progression of cancer cachexia in tumour-bearing mice.
Brown JL; Rosa-Caldwell ME; Lee DE; Blackwell TA; Brown LA; Perry RA; Haynie WS; Hardee JP; Carson JA; Wiggs MP; Washington TA; Greene NP
J Cachexia Sarcopenia Muscle; 2017 Dec; 8(6):926-938. PubMed ID: 28845591
[TBL] [Abstract][Full Text] [Related]
5. Inflammation-associated intramyocellular lipid alterations in human pancreatic cancer cachexia.
Deng M; Cao J; van der Kroft G; van Dijk DPJ; Aberle MR; Grgic A; Neumann UP; Wiltberger G; Balluff B; Schaap FG; Heeren RMA; Olde Damink SWM; Rensen SS
J Cachexia Sarcopenia Muscle; 2024 May; ():. PubMed ID: 38725139
[TBL] [Abstract][Full Text] [Related]
6. Phosphatidylethanolamine (18:2e/18:2) may inhibit adipose tissue wasting in patients with cancer cachexia by increasing lysophosphatidic acid receptor 6.
Ding Z; Han J; Huang Q; Liu X; Sun D; Sui X; Zhuang Q; Wu G
Nutrition; 2024 Apr; 120():112356. PubMed ID: 38354460
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-6 initiates muscle- and adipose tissue wasting in a novel C57BL/6 model of cancer-associated cachexia.
Pototschnig I; Feiler U; Diwoky C; Vesely PW; Rauchenwald T; Paar M; Bakiri L; Pajed L; Hofer P; Kashofer K; Sukhbaatar N; Schoiswohl G; Weichhart T; Hoefler G; Bock C; Pichler M; Wagner EF; Zechner R; Schweiger M
J Cachexia Sarcopenia Muscle; 2023 Feb; 14(1):93-107. PubMed ID: 36351437
[TBL] [Abstract][Full Text] [Related]
8. Targeting RAGE prevents muscle wasting and prolongs survival in cancer cachexia.
Chiappalupi S; Sorci G; Vukasinovic A; Salvadori L; Sagheddu R; Coletti D; Renga G; Romani L; Donato R; Riuzzi F
J Cachexia Sarcopenia Muscle; 2020 Aug; 11(4):929-946. PubMed ID: 32159297
[TBL] [Abstract][Full Text] [Related]
9. Administration of adiponectin receptor agonist AdipoRon relieves cancer cachexia by mitigating inflammation in tumour-bearing mice.
Massart IS; Kouakou AN; Pelet N; Lause P; Schakman O; Loumaye A; Abou-Samra M; Deldicque L; Bindels LB; Brichard SM; Thissen JP
J Cachexia Sarcopenia Muscle; 2024 Apr; ():. PubMed ID: 38572511
[TBL] [Abstract][Full Text] [Related]
10. Identification of a Specific Plasma Sphingolipid Profile in a Group of Normal-Weight and Obese Subjects: A Novel Approach for a "Biochemical" Diagnosis of Metabolic Syndrome?
Rigamonti AE; Dei Cas M; Caroli D; De Col A; Cella SG; Paroni R; Sartorio A
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108620
[TBL] [Abstract][Full Text] [Related]
11. Amiloride ameliorates muscle wasting in cancer cachexia through inhibiting tumor-derived exosome release.
Zhou L; Zhang T; Shao W; Lu R; Wang L; Liu H; Jiang B; Li S; Zhuo H; Wang S; Li Q; Huang C; Lin D
Skelet Muscle; 2021 Jul; 11(1):17. PubMed ID: 34229732
[TBL] [Abstract][Full Text] [Related]
12. Tumour-derived leukaemia inhibitory factor is a major driver of cancer cachexia and morbidity in C26 tumour-bearing mice.
Kandarian SC; Nosacka RL; Delitto AE; Judge AR; Judge SM; Ganey JD; Moreira JD; Jackman RW
J Cachexia Sarcopenia Muscle; 2018 Dec; 9(6):1109-1120. PubMed ID: 30270531
[TBL] [Abstract][Full Text] [Related]
13. Impairment of aryl hydrocarbon receptor signalling promotes hepatic disorders in cancer cachexia.
Dolly A; Pötgens SA; Thibaut MM; Neyrinck AM; de Castro GS; Galbert C; Lefevre C; Wyart E; Gomes SP; Gonçalves DC; Lanthier N; Baldin P; Huot JR; Bonetto A; Seelaender M; Delzenne NM; Sokol H; Bindels LB
J Cachexia Sarcopenia Muscle; 2023 Jun; 14(3):1569-1582. PubMed ID: 37127348
[TBL] [Abstract][Full Text] [Related]
14. Expression of Ceramide Synthases in Mice and Their Roles in Regulating Acyl-Chain Sphingolipids: A Framework for Baseline Levels and Future Implications in Aging and Disease.
Richardson WJ; Humphrey SB; Sears SM; Hoffman NA; Orwick AJ; Doll MA; Doll CL; Xia C; Hernandez-Corbacho M; Snider JM; Obeid LM; Hannun YA; Snider AJ; Siskind LJ
Mol Pharmacol; 2024 Feb; 105(3):131-143. PubMed ID: 38164625
[TBL] [Abstract][Full Text] [Related]
15. Skeletal muscle is enriched in hematopoietic stem cells and not inflammatory cells in cachectic mice.
Berardi E; Aulino P; Murfuni I; Toschi A; Padula F; Scicchitano BM; Coletti D; Adamo S
Neurol Res; 2008 Mar; 30(2):160-9. PubMed ID: 18397608
[TBL] [Abstract][Full Text] [Related]
16. 2-Deoxy-D-glucose Alleviates Cancer Cachexia-Induced Muscle Wasting by Enhancing Ketone Metabolism and Inhibiting the Cori Cycle.
Wei L; Wang R; Wazir J; Lin K; Song S; Li L; Pu W; Zhao C; Wang Y; Su Z; Wang H
Cells; 2022 Sep; 11(19):. PubMed ID: 36230949
[TBL] [Abstract][Full Text] [Related]
17. The p97-Nploc4 ATPase complex plays a role in muscle atrophy during cancer and amyotrophic lateral sclerosis.
Re Cecconi AD; Barone M; Gaspari S; Tortarolo M; Bendotti C; Porcu L; Terribile G; Piccirillo R
J Cachexia Sarcopenia Muscle; 2022 Aug; 13(4):2225-2241. PubMed ID: 35611892
[TBL] [Abstract][Full Text] [Related]
18. Platelet status in cancer cachexia progression in Apc
Cunningham P; Unger CA; Patton EA; Aiken A; Browne A; James E; Aladhami AK; Hope Rd MC; VanderVeen BN; Cardaci TD; Murphy EA; Enos RT; Velázquez KT
Front Immunol; 2023; 14():1253587. PubMed ID: 37701438
[TBL] [Abstract][Full Text] [Related]
19. Pectoralis major muscle atrophy is associated with mitochondrial energy wasting in cachectic patients with gastrointestinal cancer.
Dolly A; Lecomte T; Tabchouri N; Caulet M; Michot N; Anon B; Chautard R; Desvignes Y; Ouaissi M; Fromont-Hankard G; Dumas JF; Servais S
J Cachexia Sarcopenia Muscle; 2022 Jun; 13(3):1837-1849. PubMed ID: 35316572
[TBL] [Abstract][Full Text] [Related]
20. Adipose tissue lipolysis and energy metabolism in early cancer cachexia in mice.
Kliewer KL; Ke JY; Tian M; Cole RM; Andridge RR; Belury MA
Cancer Biol Ther; 2015; 16(6):886-97. PubMed ID: 25457061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
